Originally published by our sister publication Infectious Disease Special Edition
By Gina Shaw
Implementation of the BioFire FilmArray Blood Culture Identification 2 (BCID2; bioMérieux) panel significantly reduced time to effective therapy for bloodstream infections (BSIs) with resistant organisms, in a single-center retrospective study. The findings were presented by investigators from NYU Langone Health, in New York City, at the Making a Difference in Infectious Disease (MAD-ID)